Walter Bodmer

Q: What Schools Are Affiliated With Walter Bodmer

Walter Bodmer is affiliated with the following schools: University of Cambridge, Institute of Cancer Research, Osaka Metropolitan University, University of Oxford, Stanford University

Walter Bodmer's AcademicInfluence.com Rankings

Walter Bodmer

Biology

#424

World Rank

#766

Historical Rank

Genetics

#40

World Rank

#65

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Walter Bodmer Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Walter Fred Bodmer is a German-born British human geneticist. Early life Bodmer was born in Frankfurt, Germany. He was educated at Manchester Grammar School and went on to study the Mathematical Tripos at the University of Cambridge as a student of Clare College, Cambridge. He was awarded his PhD in 1959 from Cambridge for research on population genetics in the house mouse and Primula vulgaris supervised by Ronald Fisher.

(See a Problem?)

Walter Bodmer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An integrated map of genetic variation from 1,092 human genomes (2012) (7565)
Principles of Scientific Management (1993) (4709)
Nomenclature for factors of the HLA system, 2010 (2010) (2496)
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis (1978) (1957)
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome (1998) (1673)
Localization of the gene for familial adenomatous polyposis on chromosome 5 (1987) (1379)
Common and rare variants in multifactorial susceptibility to common diseases (2008) (1142)
p53 mutations in colorectal cancer. (1990) (1047)
A Human Genome Diversity Cell Line Panel (2002) (987)
The ABC of APC. (2001) (902)
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. (1999) (887)
Monoclonal Antibodies for Analysis of the HLA System (1979) (681)
Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. (1979) (663)
Chromosome 5 allele loss in human colorectal carcinomas (1987) (586)
Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis (1997) (522)
HL-A antigens and disease. Statistical and genetical considerations. (2008) (516)
Beta-catenin mutations in cell lines established from human colorectal cancers. (1997) (501)
Evolutionary Significance of the HL-A System (1972) (498)
APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". (2000) (493)
The Eurasian Heartland: A continental perspective on Y-chromosome diversity (2001) (478)
Cancer stem cells from colorectal cancer-derived cell lines (2010) (436)
HL-A, immune-response genes, and disease. (1974) (426)
TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS (1982) (418)
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis (1999) (393)
The fine-scale genetic structure of the British population (2015) (376)
Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. (1971) (352)
Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers (1981) (347)
Genetic pathways in colorectal and other cancers. (1999) (329)
Cancer cell lines for drug discovery and development. (2014) (303)
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. (2014) (300)
Characterization of a monoclonal anti‐β2‐microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens (1979) (298)
Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog (1999) (295)
Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer (2007) (294)
Chromosomal localization of human cellular homologues of two viral oncogenes (1982) (286)
Structure, Sequence and Polymorphism in the HLA‐D Region (1985) (280)
Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. (2003) (280)
Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. (2000) (273)
Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas (1992) (267)
Nomenclature for factors of the HLA system, 1991. (1992) (266)
Nomenclature for Factors of the HLA System, 1995 (1995) (262)
The mutation rate and cancer. (1996) (261)
Nomenclature for Factors of the HLA System, 1991 (1992) (259)
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. (2001) (255)
Polyclonal Origin of Colonic Adenomas in an XO/XY Patient with FAP (1996) (245)
Nomenclature for factors of the HLA system, 1996. (1997) (244)
Genetic Analysis with Human—Mouse Somatic Cell Hybrids (1969) (228)
Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2 (1978) (227)
Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. (2004) (222)
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors (2016) (221)
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. (1998) (220)
Nomenclature for factors of the HLA system, 2002. (2002) (220)
Evolution and function of the HLA system. (1978) (215)
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. (2006) (214)
Nomenclature for Factors of the HLA System, 1994 (1994) (214)
Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. (1995) (212)
Histocompatibility antigens, immune responsiveness and susceptibility to disease (1972) (203)
A migration matrix model for the study of random genetic drift. (1968) (199)
DNA mismatch repair genes and colorectal cancer (2000) (199)
Assignment of the structural gene for the third component of human complement to chromosome 19. (1982) (198)
APC in the regulation of intestinal crypt fission (1998) (197)
Linkage and Recombination in Evolution (1962) (197)
Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. (2002) (196)
Nomenclature for Factors of the HLA System, 2004. (2005) (194)
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway (2001) (194)
The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. (1978) (192)
Multigene amplification and massively parallel sequencing for cancer mutation discovery (2007) (191)
APC mutations are sufficient for the growth of early colorectal adenomas. (2000) (190)
Linkage and selection: theoretical analysis of the deterministic two locus random mating model. (1967) (189)
Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas (2004) (189)
Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. (1990) (179)
Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement (2001) (177)
EXPRESSION OF HLA SYSTEM ANTIGENS ON PLACENTA (1976) (173)
Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. (1993) (173)
Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer (2001) (170)
The number of balanced polymorphisms that can be maintained in a natural population. (1967) (169)
Differential Fertility in Population Genetics Models. (1965) (165)
Nomenclature for Factors of the HLA System, 1998 (1999) (160)
Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. (1983) (158)
Nomenclature for factors of the HLA system, 1998. (1999) (152)
Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. (1998) (151)
Nomenclature for factors of the HLA system, 1990. (1991) (151)
Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. (2000) (151)
A NEW LEUKOCYTE ISOANTIGEN SYSTEM IN MAN. (1964) (150)
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple” colorectal adenomas (2002) (150)
Chromosomal localisation of the human homologues to the oncogenes erbA and B. (1984) (146)
Nomenclature for factors of the HLA system, 2000. (2001) (145)
Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. (1994) (144)
Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. (1994) (144)
The Public Understanding of Science (1986) (142)
Clinical and molecular features of the hereditary mixed polyposis syndrome. (1997) (141)
Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types. (1984) (139)
How many mutations in a cancer? (2002) (138)
An insight into the genetic pathway of adenocarcinoma of the small intestine (2002) (135)
Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. (1989) (134)
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality (2003) (134)
Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. (1999) (134)
Genetic steps in colorectal cancer (1994) (133)
USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONS (1982) (133)
Monoclonal antibodies to HLA--DRw determinants. (2008) (131)
Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. (2002) (130)
Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. (1997) (130)
Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. (2003) (129)
Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. (1999) (128)
Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions. (1990) (128)
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis (2000) (128)
The role of hypermethylation of thehMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers (2000) (127)
Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas (1996) (127)
Intelligence and race. (1970) (118)
Genetic Analysis with Man–Mouse Somatic Cell Hybrids: Linkage between Human Lactate Dehydrogenase B and Peptidase B Genes (1970) (117)
The HLA system: structure and function. (1987) (115)
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags (2003) (115)
BIOCHEMICAL AND GENETIC STUDIES OF INTEGRATION AND RECOMBINATION IN BACILLUS SUBTILIS TRANSFORMATION. (1964) (114)
CDX1 is an important molecular mediator of Barrett's metaplasia. (2005) (112)
New genetic model for allelism at histocompatibility and other complex loci: polymorphism for control of gene expression. (1973) (111)
The peopling of Europe and the cautionary tale of Y chromosome lineage R-M269 (2012) (111)
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. (2003) (109)
Modelling the consequences of interactions between tumour cells. (1997) (108)
HLA ANTIGENS IN SEVERE PRE-ECLAMPSIA (1978) (107)
Nomenclature for factors of the HLA system, 1987. (1988) (106)
People of the British Isles: preliminary analysis of genotypes and surnames in a UK-control population (2011) (105)
Tumor Escape from Immune Response by Variation in HLA Expression and Other Mechanisms (1993) (105)
Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. (1998) (104)
Mechanisms of loss of HLA class I expression on colorectal tumor cells. (1996) (103)
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC (2002) (103)
Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. (1999) (102)
Sequence of an HLA-DR α-chain cDNA clone and intron-exon organization of the corresponding gene (1982) (101)
Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells (2011) (101)
Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. (1995) (101)
Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. (1998) (100)
Cloning and characterization of a gene that regulates cell adhesion (1992) (99)
Over‐expression of p53 nuclear oncoprotein in colorectal adenomas (1992) (98)
5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency (2010) (98)
Genetics and biochemistry of collagen binding-triggered glandular differentiation in a human colon carcinoma cell line. (1988) (98)
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1 (2009) (97)
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. (1997) (97)
cDNA clones coding for the heavy chain of human HLA-DR antigen. (1982) (97)
Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast‐associated determinants (1984) (96)
The CDX1–microRNA-215 axis regulates colorectal cancer stem cell differentiation (2015) (94)
Functional expression of HLA-DP genes transfected into mouse fibroblasts (1985) (93)
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies. (1982) (93)
Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope (2008) (93)
A monoclonal antibody that detects HLA-D region antigen in routinely fixed, wax embedded sections of normal and neoplastic lymphoid tissues. (1985) (92)
Two‐dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA‐DR1,2,w6 monoclonal antibody: Evidence for a third locus (1982) (90)
Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells (1998) (90)
A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer (1998) (87)
Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. (1983) (86)
Colonic pericrypt sheath cells: characterisation of cell type with new monoclonal antibody. (1987) (86)
Nomenclature for factors of the HLA system, 1991 (1992) (85)
Cancer genetics: colorectal cancer as a model (2006) (82)
Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours (1998) (81)
Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system. (1992) (81)
Demonstration of two distinct light chains in HLA‐DR‐associated antigens by two‐dimensional gel electrophoresis (1982) (81)
Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. (1996) (81)
Monoclonal antibodies to human colorectal epithelium: Markers for differentiation and tumour characterization (1987) (80)
On the increase of chromosome mutations under random mating. (1976) (80)
Isolation and N-terminal amino acid sequence of membrane-bound human HLA-A and HLA-B antigens (1976) (80)
A naked ape would have fewer parasites (2003) (79)
The Genetics of HLA and Disease Associations (1977) (79)
On the proportion of cancer stem cells in a tumour. (2010) (76)
INDIUM-111 LABELLED MONOCLONAL ANTIBODY TO PLACENTAL ALKALINE PHOSPHATASE IN THE DETECTION OF NEOPLASMS OF TESTIS, OVARY, AND CERVIX (1985) (75)
The HLA system and the analysis of multifactorial genetic disease. (1995) (73)
Screening SMAD1,SMAD2, SMAD3, andSMAD5 for germline mutations in juvenile polyposis syndrome (1999) (72)
Genetic instability is not a requirement for tumor development. (2008) (72)
A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. (1996) (71)
Nomenclature for Factors of the HLA System, 1996 (1997) (69)
HLA polymorphism in Israel. 9. An overall comparative analysis. (1978) (69)
Rare genetic variants and the risk of cancer. (2010) (69)
Immune surveillance in colorectal carcinoma (1995) (69)
A monoclonal antibody recognizing a human thymus leukemia‐like antigen associated with β2‐microglobulin (1982) (68)
Identification of HLA-DP polymorphism with DP alpha and DP beta probes and monoclonal antibodies: correlation with primed lymphocyte typing. (1987) (66)
Integration of Deoxyribonuclease-Treated DNA in Bacillus subtilis Transformation (1966) (64)
Familial adenomatous polyposis (FAP) and its gene, APC (1999) (64)
Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. (2004) (64)
Loss of HLA class‐I alleles, heavy chains and β2‐microglobulin in colorectal cancer (1992) (64)
Studies on African Pygmies. IV. A comparative study of the HL-A polymorphism in the Babinga Pygmies and other African and Caucasian populations. (1970) (64)
Genetics and serology of HL-A-linked human Ia antigens. (1977) (62)
HLA structure and function: a contemporary view. (2008) (62)
Expression of low molecular weight cytokeratin proteins in cervical neoplasia (1986) (62)
The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea (2000) (61)
Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers (2016) (61)
Integrin‐receptor‐mediated differentiation and growth inhibition are enhanced by transforming growth factor‐β in colorectal tumour cells grown in collagen gel (1989) (61)
The Evolution of Overdominance: Natural Selection and Heterozygote Advantage (1961) (61)
A basic science perspective. (1995) (61)
The genetics of homostyly in populations of Primula vulgaris (1960) (60)
Polygenic inheritance, GWAS, polygenic risk scores, and the search for functional variants (2020) (60)
Recombination and integration in Bacillus subtilis transformation: involvement of DNA synthesis. (1965) (60)
Mitochondrial DNA of Human–Mouse Cell Hybrids (1971) (59)
The HLA System, 1984 (1984) (59)
Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria (1997) (58)
Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. (1996) (58)
Structural and evolutionary analysis of HLA-D-region products (1984) (57)
HLA-A locus alleles identified by sequence specific PCR (1993) (57)
GENETICS OF “4” AND “LA” HUMAN LEUKOCYTE GROUPS * (1966) (57)
Human Ia antigens--purification and molecular structure. (1977) (57)
Human genetics: the molecular challenge. (1987) (57)
Rapid isolation of human chromosome-specific DNA probes from a somatic cell hybrid. (1990) (57)
Examples of Mathematical Modeling: Tales from the Crypt (2007) (56)
Rare Variant Hypothesis for Multifactorial Inheritance: Susceptibility to Colorectal Adenomas as a Model (2005) (56)
Nomenclature for factors of the HLA system, 1991 (1992) (55)
MSI‐low, a real phenomenon which varies in frequency among cancer types (2003) (54)
Biochemistry of Class II Antigens: Workshop Report (1984) (54)
Genetic characteristics of the HeLa cell. (1976) (54)
Genetics of the human face: Identification of large-effect single gene variants (2018) (54)
Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells (2008) (54)
Control of differentiation in human colorectal carcinoma cell lines: Epithelial—mesenchymal interactions (1988) (54)
Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression. (1999) (54)
Expression of HLA-A, -B, and -C and beta 2-microglobulin antigens in human choriocarcinoma cell lines. (1980) (53)
Permanent lymphoid lines from genetically marked lymphocytes: success with lymphocytes recovered from frozen storage. (2008) (53)
Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours (1996) (53)
Human genetics: the molecular challenge. (1987) (53)
Serum marker potential of placental alkaline phosphatase-like activity in testicular germ cell tumours evaluated by H17E2 monoclonal antibody assay. (1985) (52)
Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer (1998) (52)
HIV TESTING ON ALL PREGNANT WOMEN (1987) (52)
The HLA system: introduction. (1978) (52)
Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. (1997) (52)
SELECTIVE LOSS OF HLA-A,B,C LOCUS PRODUCTS IN COLORECTAL ADENOCARCINOMA (1988) (51)
Genotyping Possible Polymorphic Variants of Human Mismatch Repair Genes in Healthy Korean Individuals and Sporadic Colorectal Cancer Patients (2004) (51)
Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes. (1987) (51)
Nomenclature for factors of the HLA system, 1991. (1992) (51)
Separation of cancer cells from white blood cells by pinched flow fractionation. (2015) (51)
123I radioiodinated antibody imaging of occult ovarian cancer (1985) (51)
Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice. (2005) (49)
Genetic Control of Mitochondrial Enzymes in Human–Mouse Somatic Cell Hybrids (1973) (49)
Nomenclature for factors of the HLA system, 1989. (1990) (46)
Nomenclature for factors of the HLA System, 1996. (1997) (46)
Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. (1986) (46)
Nomenclature for factors of the HLA system, 2002. (2002) (46)
Mutations in the AXIN1 gene in advanced prostate cancer. (2009) (45)
The search for a human equivalent of the mouse T-locus - negative results from a study of HL-A types in spina bifida. (1975) (44)
An update to HLA Nomenclature, 2010 (2010) (44)
A family study of the association between insulin dependent diabetes mellitus, autoantibodies and the HLA system. (1984) (44)
Monoclonal antibodies to HLA-DP-transfected mouse L cells. (1986) (44)
An epitope on carcinoembryonic antigen defined by the clinically relevant antibody PR1A3. (1994) (44)
Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors. (2013) (43)
The immune response to vasectomy and its relation to the HLA system. (2008) (43)
Nomenclature for factors of the HLA system, 1984. (1984) (43)
Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice. (2002) (43)
Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel (2012) (43)
CpG island clones from a deletion encompassing the gene for adenomatous polyposis coli. (1989) (42)
Integrin cell adhesion molecules and colorectal cancer (1990) (42)
An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase. (1984) (42)
Relationship of Centromeric Heterochromatin to Fluorescent Banding Patterns of Metaphase Chromosomes in the Mouse (1971) (42)
MHC antigens and cancer: Implications for T-cell surveillance (1992) (42)
Uptake and Incorporation of Thymine, Thymidine, Uracil, Uridine, and 5-Fluorouracil into the Nucleic Acids of Bacillus subtilis (1965) (41)
Nomenclature for factors of the HLA system, 1989. (1990) (41)
Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease. (1993) (41)
Use of microimmobilization and microagglutination assays for attempted detection of HLA antigens and beta2 microglobulin on human sperm. (1978) (40)
GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. (2006) (40)
Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer. (1997) (40)
Nomenclature for factors of the HL-a system. (1998) (40)
Disease associations and altered immune function in CD45 138G variant carriers. (2004) (40)
MHC antigens and cancer: implications for T-cell surveillance. (1992) (39)
HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer. (1993) (39)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1995 (1995) (38)
Nomenclature for factors of the HLA system, 1994. (1994) (38)
Evolution of the Rh polymorphism: a model for the interaction of incompatibility, reproductive compensation, and heterozygote advantage. (1969) (38)
The William Allan Memorial Award Address: Gene clusters, Genome organization, and complex phenotypes. When the sequence is known, what will it mean? (1981) (38)
Nomenclature for factors of the HLA system, 1995. (1995) (38)
The Book Of Man: The Quest To Discover Our Genetic Heritage (1995) (38)
Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes. (1996) (38)
A pericentric inversion of chromosome six in a patient with Peutz-Jeghers’ syndrome and the use of FISH to localise the breakpoints on a genetic map (1996) (37)
A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitro (1981) (36)
Myofibroblast activation in colorectal cancer lymph node metastases (2013) (36)
Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. (1997) (36)
Nomenclature for factors of the HLA system 1984 (2004) (36)
Nomenclature for Factors of the HLA System, 1998 (1999) (35)
The role of the arginine-glycine-aspartic acid-directed cellular binding to type I collagen and rat mesenchymal cells in colorectal tumour differentiation. (1991) (35)
hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer. (2001) (35)
Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. (1982) (35)
Discrete Stochastic Processes in Population Genetics (1960) (34)
A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression (2003) (34)
HLA haplotype associations with disease. (2008) (34)
HLA and cancer: 12th International Histocompatibility Workshop study (1997) (34)
Monoclonal antibodies to HLA determinants. (1984) (34)
The Somatic Evolution of Cancer (1997) (34)
CDX2 mutations do not account for juvenile polyposis or Peutz–Jeghers syndrome and occur infrequently in sporadic colorectal cancers (2001) (33)
The initial progress of new genes with various genetic systems (1960) (33)
HLA-DP BASED RESISTANCE TO HODGKIN'S DISEASE (1989) (33)
Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours. (1985) (33)
Cross-reactions of cattle lymphocytotoxic sera with HL-A and other human antigens. (2008) (32)
HLA-D region antigen-associated invariant polypeptides as revealed by two-dimensional gel analysis. Glycosylation and structural inter-relationships. (1985) (32)
CD1c antigens are present in normal and neoplastic B‐cells (1988) (32)
Successful Science Communication: Telling It Like It Is (2011) (32)
Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis (2009) (32)
Stromal uptake and transmission of acid is a pathway for venting cancer cell-generated acid (2016) (32)
Human intraspecific somatic cell hybrids: A genetic and karyotypic analysis of crosses between lymphocytes and D98/AH-2 (1975) (31)
Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability. (1996) (31)
Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma (1999) (31)
Rapidly derived colorectal cancer cultures recapitulate parental cancer characteristics and enable personalized therapeutic assays (2014) (30)
Lack of expression of HLA antigens on choriocarcinoma cell lines. (2008) (30)
MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions (2010) (30)
Public Understanding of Science: The BA, the Royal Society and COPUS (2010) (30)
Microsatellite instability in benign skin lesions in hereditary non-polyposis colorectal cancer syndrome. (1999) (30)
The HLA System and Disease (1980) (30)
The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles. (1995) (30)
APC mutation associated with late onset of familial adenomatous polyposis. (1994) (30)
Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy. (1993) (29)
Gene clusters and the evolution of the major histocompatibility system. (1986) (29)
HLA: a super supergene. (1978) (29)
Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen (2008) (29)
Comprehensive assessment of variation at the transforming growth factor β type 1 receptor locus and colorectal cancer predisposition (2010) (29)
The HL-A System as a Model for Studying the Interaction between Selection, Migration, and Linkage (1976) (29)
CLINICO‐PATHOLOGICAL FEATURES AND p53 EXPRESSION IN LEFT‐SIDED SPORADIC COLORECTAL CANCERS WITH AND WITHOUT MICROSATELLITE INSTABILITY (1996) (29)
Antigenic expression and cross reactions in HL-A variants of lymphoid cell lines. (2008) (28)
Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas (1997) (27)
Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas. (1996) (27)
Genetics of HLA: the major human histocompatibility system (1978) (27)
Serologic characterization of human Ia antigens using B-cell lymphoid lines. (1977) (27)
Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling. (2014) (26)
The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland (2017) (25)
The structure and evolution of the HLA--Bw4 and Bw6 antigens. (2008) (25)
EpCAM and gpA33 are markers of Barrett’s metaplasia (2006) (25)
Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection (2006) (25)
A sensitive micro-immunoassay using β-galactosidase/ anti-β-galactosidase complexes (1987) (25)
Research to improve public understanding programmes (1992) (24)
Genetic factors in Hodgkin's disease: association with a disease-susceptibility locus (DSA) in the HL-A region. (1973) (24)
Linkage disequilibrium and age of HLA region SNPs in relation to classic HLA gene alleles within Europe (2010) (24)
Genetic Characterization of Human Populations: From ABO to a Genetic Map of the British People (2015) (24)
Natural crossing between homostyle plants of Primula vulgaris (1958) (24)
Effects of Maternal Age on the Incidence of Congenital Abnormalities in Mouse and Man (1961) (24)
Nomenclature for factors of the HLA system, 1994. (1994) (23)
Viability effects and recombination differences in a linkage test with pallid and fidget in the house mouse (1961) (22)
Variation in HLA expression on tumors: an escape from immune response. (1989) (22)
New vector for transfer of yeast artificial chromosomes to mammalian cells (1993) (22)
GERM CELL TUMOURS OF THE TESTICLE AS A MODEL OF MHC INFLUENCE ON HUMAN MALIGNANCY (1986) (21)
HLA: what's in a name? (1997) (21)
Characterization and mapping of microdissected genomic clones from the adenomatous polyposis coli (APC) region. (1991) (21)
Demographic approaches to the measurement of differential selection in human populations. (1968) (21)
Chromosome 11q in sporadic colorectal carcinoma: patterns of allele loss and their significance for tumorigenesis. (1996) (21)
Recombination and DNA replication in Bacillus subtilis transformation. (1968) (21)
Cytostatic drug treatment causes seeding of gene promoter methylation (2007) (21)
Two MspI polymorphisms within the APC gene. (1992) (20)
Distribution of HLA antigens in Ticuna Indians of Brazil: results of typing a leprosy-affected family. (2008) (20)
Nomenclature for factors of the HLA system--1977. (1978) (19)
Single-molecule DNA-mapping and whole-genome sequencing of individual cells (2018) (19)
Histocompatibility 1984. (1984) (18)
Production of specific antisera to human B lymphocytes. (2008) (18)
Independent expression of HLA and beta2 microglobulin on human-mouse hybrids. (1976) (18)
Media wars (1996) (18)
Molecular structure of the gene products of the human HLA system: isolation and characterization of HLA-A, -B, -C and Ia antigens (1978) (18)
Genetic analysis of colorectal cancer. (1989) (18)
Hybrids between human leukocytes and a mouse cell line: production and characterization. (1969) (18)
HLA Polymorphism and Evolution (1999) (18)
Combined analysis of three studies of patients with Burkitt's lymphoma. (2008) (17)
Theoretical consideration of leukocyte grouping using multispecific sera (1966) (17)
Support for genetic diversity project (1997) (17)
Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test (1997) (17)
Replication error deficient and proficient colorectal cancer gene expression differences caused by 3′UTR polyT sequence deletions (2010) (17)
The specificity of naturally occurring heterophile antibodies in normal rabbit serum. (2008) (16)
Leucocyte Antigens in Man : A Comparison of Lymphocytotoxic and Agglutination Assays for their Detection (1966) (16)
DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load. (1997) (16)
Expression and segregation of HL-A antigens in D98/AH-2 by lymphocyte and fibroblast hybrids. (2008) (16)
The separation of cell populations using monoclonal antibodies attached to sepharose. (2008) (16)
Population genetics of the HL-A system. A summary of data from the Fifth International Histocompatibility Testing Workshop. (1973) (16)
Somatic cell genetics and cancer. (1988) (16)
Intron splice acceptor site sequence variation in the hereditary non-polyposis colorectal cancer gene hMSH2. (1994) (16)
5-AZACYTIDINE FOR BETA-THALASSAEMIA? (1983) (16)
Distribution and Quantity of Leukocyte Antigens in the Formed Elements of the Blood (1966) (15)
Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma. (2000) (15)
PREPARATION AND CHARACTERIZATION OF 15N2H3H-LABELED DNA FROM BACILLUS SUBTILIS AND ESCHERICHIA COLI PHAGE T2. (1964) (15)
T-cell immune responses to cancer--a new look. (1991) (15)
The book of man : the Human Genome Project and the quest to discover our genetic heritage (1995) (14)
Population genetics of tumours. (1996) (14)
Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients (2011) (14)
Models and mechanisms for HLA and disease associations. (1980) (14)
Events occurring at the site of integration of a DNA molecule in Bacillus subtilis transformation. (1968) (14)
A reassessment of the HL-A system in Khoisan populations of South West Africa. (1975) (14)
Gene clusters and the HLA system. (1979) (14)
A new look at tumour immunology. (1992) (14)
DNA Polymorphism of HLA-DRβ and HLA-DPβ Genes (1984) (14)
A monoclonal antibody to intestinal alkaline phosphatase made against D98/AH-2 (HeLa) cells. (2008) (14)
Evolution and function of the HLA region. (1995) (13)
CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans (2004) (13)
Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery (2002) (13)
Nomenclature for factors of theHLA system, 1991 (1992) (13)
A rapid micro method for counting cells “in situ” using a fluorogenic alkaline phosphatase enzyme assay (2007) (13)
Fine Mapping of Probes in the Adenomatous Polyposis Coli Region of Chromosome 5 by In Situ Hybridization (1991) (13)
Chromosomal assignment of seven human genomic DNA sequences associated with restriction fragment length polymorphisms (1986) (13)
The rate of production of recombinants between linked genes in finite populations (1967) (13)
Evolution of HL-A and other major histocompatibility systems. (1975) (13)
Alkaline-mediated differential interaction (AMDI): A simple automatable single-nucleotide polymorphism assay (2001) (13)
1998 Runme Shaw Memorial Lecture: somatic evolution of cancer. (1999) (13)
PCR-based detection of two MspI polymorphic sites at D18S8. (1991) (13)
High-throughput class I HLA genotyping using fluorescence resonance energy transfer (FRET) probes and sequence-specific primer-polymerase chain reaction (SSP-PCR). (1999) (12)
HLA and genetic marker studies in adenomatous polyposis (1985) (12)
Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors (2001) (12)
9 – Genetics of Colorectal Cancer (1991) (12)
Genetic diversity and disease susceptibility. (1997) (12)
Report of the committee on the genetic constitution of chromosome 6. (1976) (12)
Nomenclature for factors of the HLA system--1977. (1977) (12)
Population stratification as an explanation of IQ and ABO association (1975) (12)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1990 (1991) (12)
5-bromouracil utilization by Bacillus subtilis (1967) (11)
Sex and generations of primroses (1984) (11)
HLA: what's in a name? A commentary on HLA nomenclature development over the years. (1997) (11)
The Analysis of Genetic Variation Using Migration Matrices (1974) (11)
Biochemical analysis of the polymorphism of three HLA-D region antigens. (1983) (11)
The molecular staging of prostate cancer (2005) (11)
Preclinical Application of Radioimmunoguided Surgery Using Anti-Carcinoembryonic Antigen Biparatopic Antibody in the Colon Cancer (2005) (11)
Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test. (1997) (11)
Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene. (1982) (11)
Assignment of the gene for the thrid component of human complement (C3) to chromosome 19 using human mouse somatic cell hybrids (1982) (11)
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study (2005) (11)
IMMUNOLOGY AND THE FETUS (1978) (11)
Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancer (2012) (11)
The fitness of human translocation carriers (1976) (10)
Experiments on animals (1989) (10)
Growth factor requirements of human colorectal tumour cells: relations to cellular differentiation. (1991) (10)
Carcino‐embryonic antigen may function as a chemo‐attractant in colorectal‐carcinoma cell lines (1999) (10)
Nomenclature for factors of the HLA system--1977. (1978) (10)
CRISPR-Cas9 screen identifies oxidative phosphorylation as essential for cancer cell survival at low extracellular pH (2022) (10)
Geographical distribution and disease associations of the CD45 exon 6 138G variant (2006) (10)
RA Fisher, statistician and geneticist extraordinary: a personal view. (2003) (10)
HL-A and Burkitt's tumour--a study in Uganda. (2008) (10)
PLAP -CAR T cells mediate high specific cytotoxicity against colon cancer cells. (2020) (10)
Sequencing of human genomes extracted from single cancer cells isolated in a valveless microfluidic device. (2018) (9)
A somatic cell hybrid panel for regional mapping of human chromosome 18. (1992) (9)
Two monoclonal antibodies identifying a subset of human peripheral mononuclear cells with natural killer cell activity (1983) (9)
A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with beta 2-microglobulin. (1982) (9)
MITOCHONDRIAL ENZYMES IN MAN-MOUSE HYBRID CELLS (1974) (9)
Tumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimeras. (1999) (9)
Detection of a 4-bp insertion (CACA) functional polymorphism at nucleotide 241 of the cellular adhesion regulatory molecule CMAR (formerly CAR). (1994) (9)
BIOLOGICAL SIGNIFICANCE OF BETA hCG, HLA AND OTHER MEMBRANE ANTIGEN EXPRESSION ON BLADDER TUMOURS AND THEIR RELATIONSHIP TO TUMOUR INFILTRATING LYMPHOCYTES (TIL) (1989) (9)
HLA today. (1986) (9)
Prostate cancer 2000 (2000) (9)
The human chromosome content in human x rodent somatic cell hybrids analyzed by a screening technique using Alu PCR. (1991) (9)
Nomenclature for factors of the HLA system, 2004. (2005) (9)
Early British discoveries in human genetics: contributions of R.A. Fisher and J.B.S. Haldane to the development of blood groups. (1992) (8)
Multiplicative effects and the logarithmic transformation in the analysis of balanced multi-point linkage tests (1959) (8)
Genotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer (2021) (8)
Synthesis of HLA antigens from membrane-associated messenger RNA. (1980) (8)
The human genome sequence and the analysis of multifactorial traits. (1987) (8)
Tissue-typing instrumentation using the fluorochromatic cytotoxicity assay. (1970) (8)
The analogy between factorial experimentation and balanced multi-point linkage tests (1959) (8)
Genomic landscape of colorectal carcinogenesis (2022) (8)
Nomenclature for Factors of the HLA System 1984 (1985) (8)
Inclusion analysis of Fifth Histocompatibility Testing Workshop sera in 25 populations. (1975) (8)
Six HLA-D region a-chain genes on human chromosome 6: Polymorphisms and associations of DCa-related sequences with DR types (7)
PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging. (2008) (7)
Subdividing Y-chromosome haplogroup R1a1 reveals Norse Viking dispersal lineages in Britain (2020) (7)
Histocompatibility testing international (1975) (7)
PERMANENT LYMPHOID LINES FROM GENETICALLY MARKED LYMPHOCYTES - SUCCESS WITH MAILED BLOOD SAMPLES AND FROZEN LYMPHOCYTES (1975) (7)
A long-range restriction map of human chromosome 5q21-q23. (1993) (7)
Radioimmune diagnosis of ovarian carcinoma using tumor-associated monoclonal antibodies (1983) (7)
Scientific Literacy for Health and Prosperity. (1989) (7)
Ruggero Ceppellini: A Perspective on His Contributions to Genetics and Immunology (2019) (7)
Interaction of modifiers: The effect of pallid and fidget on polydactyly in the mouse (1960) (7)
Serologic activities and specificities of eleven human leukocyte antisera produced by planned immunization. (1967) (7)
OESOPHAGEAL CANCER IN CHINA (1989) (7)
Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of b -catenin (2000) (7)
The human genome project. (1994) (6)
Commentary How Many Mutations in a Cancer (2002) (6)
Successful Science Communication: And finally, evaluating and embedding science communication (2011) (6)
An isolated β1 exon next to the DRα gene in the HLA-D region (2004) (6)
Nomenclature for Factors of the HLA System, 1989 (1990) (6)
Ruggero Ceppellini 1917–1988 (2004) (6)
Population studies and the measurement of natural selection, with special reference to the HL-A system. (1973) (6)
Hereditary Colorectal Cancer: A Commentary (1990) (6)
The major histocompatibility gene clusters of man and mouse. (1981) (6)
Studies on the Replication of DNA by Escherichia coli Polymerase (1963) (6)
Isolation and sequencing of a cDNA clone for a human HLA-ABC antigen. (1984) (6)
PHYSICAL MAPPING OF THE APC REGION (1991) (6)
Detection of cKi-ras mutations in faecal samples from sporadic colorectal cancer patients (2006) (6)
Critical roles for EGFR and EGFR–HER2 clusters in EGF binding of SW620 human carcinoma cells (2022) (6)
Cancer genetics and the human genome. (1991) (6)
Author Correction: The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland (2018) (6)
The Expression of HLA-DR, DQ and DP Antigens on the Surface of Lymphocytes as Assessed by 2-D Polyacrylamide Gel Analysis of Immunoprecipitates (1984) (6)
HLA, Immune Response, and Disease (1987) (5)
The Role of TGFβs in Controlling Cell Adhesion and Differentiation of Colon Carcinoma Cells (1990) (5)
Of altered antibodies. (1988) (5)
Analysis of the Mitochondrial Enzymes Citrate Synthase (EC 4.1.3.7) and Malate Dehydrogenase (EC 1.1.1.37) in Human-Mouse Somatic Cell Hybrids (1974) (5)
Variation in fitness in molecular evolution (1972) (5)
A rapid method for the analysis of cell proliferation and survival in intestinal adenoma from the Apc(Min) mouse (2001) (5)
Radioimmunodetection of Cancer. (1982) (5)
Monoclonal antibodies: their role in human genetics. (1982) (5)
Sequences related to HLA-DRa chain on human chromosome 6: Restriction enzyme polymorphism detected with DCa chain probes (5)
Commentary: Connections between genetics and statistics: a commentary on Fisher's 1951 Bateson lecture--'Statistical Methods in Genetics'. (2010) (5)
Natural selection for modifiers of heterozygote fitness. (1963) (5)
A PROGRAM FOR GENETIC DEMOGRAPHY BASED ON DATA FROM LARGE-SCALE SOCIAL SURVEYS. (1965) (5)
The outstanding scientist, R.A. Fisher: his views on eugenics and race (2021) (5)
Perspectives in genetic demography. (1967) (5)
The book of man (1994) (5)
HLA-A, -B, -Cw, -DQA1 and -DRB1 allele frequencies in a population from Orkney, Scotland (2004) (5)
Genetic pathways in colorectal and other cancers. (1999) (5)
Genetic sequences (1990) (5)
Sam Karlin: a personal appreciation. (2009) (4)
Factorial analysis of balanced four- and higher-point linkage tests (1959) (4)
Cellular polarity modulates drug resistance in primary colorectal cancers via orientation of the multidrug resistance protein ABCB1 (2019) (4)
A sensitive micro-immunoassay using beta-galactosidase/anti-beta-galactosidase complexes. (1987) (4)
Lymphocytotoxic sera associated with ABO and Lewis red cell blood groups. (1972) (4)
Genomic and cDNA sequence analysis of the cell matrix adhesion regulator gene. (1997) (4)
The museum that has to change (1990) (4)
The strategy of gene assignment using hybrids: the number of lines needed to exclude chance associations. (1975) (4)
A mutated HLA-A*0101 allele in the colorectal cell line HCA-7. (2005) (4)
Our future inheritance : choice or chance? : a study (1974) (3)
Somatic selection of poorly differentiating variant stem cell clones could be a key to human ageing. (2020) (3)
Genetics of the cell surface (1978) (3)
Radiotherapy's second setback (1989) (3)
Predictability of trophoblast tumor outcome based on chromosome constitution (1980) (3)
The HL-A system. (1978) (3)
14. Statistics And Population Genetics Of The HLA System (1989) (3)
Antisera recognising HLA-A, -B and DRW antigens raised in rhesus monkeys. (2008) (3)
Cellular distrubtion, purification, and molecular nature of human Ia antigens. (1977) (3)
Characterisation of the HLA-D Region DQw3 Specificity Using the Monoclonal Antibodies 2HB6 and IVD12 (1984) (3)
A Significantly Extreme Deviate in Data with a Non-Significant Heterogeneity Chi Square (1959) (3)
Histocompatibility testing 1977 : report of the 7th International Histocompatibility Workshop and Conference : the workshop conference took place in Oxford, England from 4-10 September, 1977 (1977) (3)
Cloning and characterization of a gene that regulates cell adhesion. (1992) (3)
Some further data on the joint segregation of HL‐A and haptoglobin (1971) (3)
Mutations of the APC (adenomatous polyposis coli) gene in human cancers. (1994) (3)
Nomenclature for Factors of the HLA System 1977 (1977) (3)
Role of IL-1 in the Activation and Inactivation of Human T-Cell Clones: Relevance to Rheumatological Disease (1985) (3)
Analysis of circulating tumor cells in prostate, colorectal and ovarian cancer using robotic microscopy (2008) (3)
WHO‐IUIS TERMINOLOGY COMMITTEE NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM (1976) (3)
Cancer prevention in central and eastern Europe. (1992) (3)
Nomenclature for factors of the HLA system, 2000. (2001) (3)
Serological identification of Ia antigens: report of a British region Ia workshop. (1976) (3)
Cancer and Evolution (2006) (3)
Molecular and clinico-pathological features of two families with the HNPCC syndrome and unusual phenotypes (1997) (2)
Isolation of a polymorphic DNA sequence (lambda EMBL3.287, D8S8) from chromosome 8. (1986) (2)
The biological significance, isolation and structure of histocompatibility antigens. (1976) (2)
Nomenclature for Factors of the HLA System‐1977 1 (1979) (2)
MOLECULAR MECHANISM OF RECOMBINATION IN BACILLUS SUBTILIS TRANSFORMATION. (1969) (2)
The Evolution of Human Hairlessness: Cultural Adaptations and the Ectoparasite Hypothesis (2004) (2)
Human Histocompatibility Antigens (1971) (2)
Nomenclature for factors of the HLA system, 1995, update June 1995 (1995) (2)
Molecular Genetics of the HLA Region (1984) (2)
Isolation of a polymorphic DNA sequence (λEMBL3.121, D14S12) from chromosome 14 (1986) (2)
In Vitro Analyses of Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells for Anticancer Study (2020) (2)
UNDIFFERENTIATED CELLS, METAPLASIA, c-myc EXPRESSION, AND GASTROINTESTINAL CARCINOGENESIS (1989) (2)
PATTERNS OF CROSS-REACTIVITY IN 7TH WORKSHOP IA SERA (1977) (2)
An isolated beta 1 exon next to the DR alpha gene in the HLA-D region. (1986) (2)
Regional mapping of 22 microclones around the adenomatous polyposis coli (APC) locus on chromosome 5q (1991) (2)
A new RFLP for L1.4 (D5S4) an anonymous genomic clone localised to chromosome 5. (1987) (2)
Modelling multiscale aspects of colorectal cancer (2008) (2)
Nomenclature for factors of the HLA System, 1998. (1999) (2)
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. (1992) (2)
5th Histocompatibility Workshop. Introduction. (1975) (2)
Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system. (1991) (2)
Development and validation of ColoScape: A new colorectal cancer mutation detection assay. (2018) (2)
Rose Payne 1909-1999. With personal recollections by Julia and Walter Bodmer. (1999) (2)
Analysis of negative and multiple HLA antigen disease associations. (2008) (2)
Nomenclature for factors of the HLA system, 1996. (1997) (2)
GMMchi: gene expression clustering using Gaussian mixture modeling (2022) (2)
Cancer genetics. (1994) (2)
The Genetics of Human Populations (1972) (2)
Fisher and Bradford Hill: a discussion (2003) (2)
A NEW LOOK AT TUMOR IMMUNOLOGY - INTRODUCTION (1992) (2)
A Mathematician's Odyssey. (2015) (2)
On the convergence of iterative processes for the solution of simultaneous equations in several variables (1960) (2)
TaqI RFLP for the IL2RA locus. (1994) (1)
Nomenclature for factors of the HLA system, 2002. (2002) (1)
HUGO: The Human Genome Organisation (1990) (1)
21st Meeting of the Irish Society of Human Genetics (2019) (1)
SOMATIC-CELL GENETICS AND LHA SYSTEM (1977) (1)
Identification of colorectal cancer stem cells that self-renew, differentiate and drive tumour growth (2010) (1)
Molecular genetics research in sub-Saharan Africa: how can the international community help? (2014) (1)
Isolation of a polymorphic DNA sequence (λEMBL3.303, D2S14) from chromosome 2 (1986) (1)
HLA AND DISEASE (1979) (1)
Genetic analysis with human-mouse hybrid cells. (1971) (1)
Colorectal cancer stem cells and intestinal stem cells: The two faces of janus (2012) (1)
Identification of HLA-DP polymorphism with DPa and DP , 8 probes and monoclonal antibodies : Correlation with primed lymphocyte typing ( major histocompatibility complex / restriction fragment length polymorphism / ELISA ) (1)
Sequencing Metrics of Human Genomes Extracted from Single Cancer Cells Individually Isolated in a Valveless Microfluidic Device (2018) (1)
Flaws in GMAG's guidelines (1979) (1)
ASHI conference, Vancouver, Canada, October 10th, 1998 (1999) (1)
European camparison populations needed, can you help? (2007) (1)
Summary of the 12th International Histocompatibility Workshop and Conference (1997) (1)
P01.01 PLAP as target for cancer immunotherapy – development and preclinical characterization of bispecific monoclonal antibody in colorectal cancer immunotherapy (2022) (1)
Glycosylation and biosynthesis of human HLA-D region antigen-associated invariant polypeptides (1984) (1)
Erratum: Cloning and characterization (Nature (1992) 356 (529-532)) (1993) (1)
Some Reflections on Mechanisms and Prospects of Genetic Exchange (1972) (1)
EVOLUTION AND STABILITY OF SPECIES (1979) (1)
Genetic testing and insurance (1996) (1)
Serendipitous cloning of a mitochondrial cDNA and its polymorphism. (1984) (1)
Independent expression of HLA and beta2 microglobulin on human-mouse hybrids. (1976) (1)
Characterization of antibodies reacting with husband's lymphocytes in sera from patients with trophoblastic malignancies. (2008) (1)
Leucocyte antigens in man: A comparison of lymphocytotoxic and agglutination assays for their detection (1966) (1)
Top-down or bottom-up morphogenesis of colorectal adenomas: Competing management structures in the origins of colonic neoplasia (2003) (1)
Molecular genetics of the HLA system. (1982) (1)
Human Evolution at the Crossroads (Review of "Essays of a Humanist" by Julian Huxley) (1964) (1)
Protein clinical manifestations of primary tumors of the heart. (1972) (1)
Sequencing of autosomal, mitochondrial and Y-chromosomal forensic markers in the People of the British Isles cohort detects population structure dominated by patrilineages. (2022) (1)
Cancers and Is a Nonrandomly Distributed Quantitative Trait Low-Level Microsatellite Instability Occurs in Most Colorectal (2001) (1)
Production of Defined Human Leukocyte Typing Sera (1972) (1)
Somatic mutations of the first 14 exons of APC in hamartomatous polyps of the colon (1999) (1)
The isolation and description of LIF-10: A human tumor cell line derived from a colorectal adenocarcinoma (1990) (1)
Building relations with the various groups (2011) (1)
Caution about assay of alkaline phosphatase to quantitate cell numbers (1989) (1)
Joshua Lederberg. 23 May 1925 — 2 February 2008 (2011) (1)
The Limiting Frequencies of Integers with a Given Partitional Characteristic (1959) (1)
Molecular mechanisms of the immune response (1995) (1)
Physical Heterogeneity Among Bacillus subtilis Deoxyribonucleic Acid Molecules Carrying Particular Genetic Markers (1969) (1)
Report on Chromosome 6 (1975) (1)
Things to see and do: how scientific images work (2011) (1)
Genetic testing is important in families with a history suggestive of hereditary non‐polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled (1997) (1)
The evolution of recombination mechanisms in bacteria (1972) (1)
Genetic patterning in Central Eurasia: population history and pigmentation (2018) (1)
Publicity and priority (1983) (1)
Looking Looking Back, Forward INTRODUCTION (2011) (1)
Isolation of a polymorphic DNA sequence (lambda EMBL3.121, D14S12) from chromosome 14. (1986) (1)
Medical genetics in China. (1979) (1)
Plasma ctDNA multigene mutation analysis for the diagnosis and treatment monitoring of colorectal cancer patients (2018) (0)
Population Genetics: the study of the genetic structure of human populations (2015) (0)
Genetic and Epigenetic Alterations of CDKN2A, B in Colorectal Cancer Cell Lines (2002) (0)
Possible involvement of HLA in determining clinical behaviour of germ cell tumours of the testicle (1985) (0)
The Newfoundland and Labrador mosaic founder population descends from an Irish and British diaspora from 300 years ago (2023) (0)
Places: The imperial cancer research fund (1984) (0)
new monoclonal antibody . characterisation of cell type with Colonic pericrypt sheath cells : (2005) (0)
Colorectal cancer stem cells: Characterization and functional analysis. (2009) (0)
343 Cancer genetics (1995) (0)
Author Index (2005) (0)
Prostate Cancer Charitable Trust 2004 Forum: a personal overview (2004) (0)
96P Goblet cell differentiation in colorectal cancer (2022) (0)
Solute exchange through gap junctions lessens the adverse effects of inactivating mutations in metabolite-handling genes (2022) (0)
Monoclonal antibodies used for diagnosis and treatment of colorectal cancer. (1994) (0)
Analysis of linkage disequilibrium within the HLA region in 10 European populations (2008) (0)
Subdividing Y-chromosome haplogroup R1a1 reveals Norse Viking dispersal lineages in Britain (2020) (0)
FOREWORD – HLA POLYMORPHISM: ORIGIN AND MAINTENANCE (2000) (0)
List of contributors (2021) (0)
The implications of the human genome sequence for cancer research (2001) (0)
A novel xenonucleic acid mediated molecular clamping technology for early colorectal cancer diagnostics. (2020) (0)
E-cadherin mutations in human colorectal cancer cell lines (1999) (0)
Imperial Cancer Research Fund British Association for Cancer Research. Joint symposium held at the Royal College of Surgeons, Lincolns Inn Fields, London 30 November--1 December 1978. Abstracts of papers. (1979) (0)
Germline HNPCC genevariants havelittle influence on therisk forsporadic colorectal cancer (1997) (0)
Letter from Walter F. Bodmer to Joshua Lederberg (1961) (0)
Determination of the clonality of colorectal tumours; Clues to the origin of human cancer (1997) (0)
Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy (2022) (0)
EHPnet: Pesticides and People (1999) (0)
Whooping-cough immunisation. (1977) (0)
Letter from Walter F. Bodmer to Victor A. McKusick (1975) (0)
HUGO: The Human Genome Organization 1 (1991) (0)
Medicine and Books (1988) (0)
EGF Signaling in Epithelial Carcinoma Cells Utilizes Higher Order Architectures of EGFR and HER2 (2020) (0)
HL-A SYSTEM IN MAN - GENETICS, FUNCTIONS AND CHEMISTRY (1975) (0)
Fear of Enlightenment (1971) (0)
The Imperial Cancer Research Fund in the 1980s. (1990) (0)
Sir Walter Bodmer FRS in interview with Dr Max Blythe: Interview 1 (2017) (0)
Abstracts of papers from the discussion meeting on mathematical genetics (1983) (0)
Genetic screening--the social dilemma. (1974) (0)
Target genes of f8-catenin-T cell- signaling in human colorectal cai (2016) (0)
Mathematical genetics : proceedings of a Royal Society discussion meeting held on 20 April 1983 (1983) (0)
ABNORMALITIES IN HLA EXPRESSION ON COLORECTAL TUMOR-CELL LINES - IMPLICATIONS FOR ANTIGEN PRESENTATION (1993) (0)
A New Look at Tumour (1992) (0)
Demographic and Epidemiological Studies (1963) (0)
Newfoundland and Labrador: A mosaic founder population of an Irish and British diaspora from 300 years ago (2022) (0)
Bristol Cancer Help Centre (1990) (0)
The common language of research (2011) (0)
Somatic genetics and signaling/genomics/proteomics (2003) (0)
Human genome dispute (1991) (0)
SOMATIC-CELL GENETICS (1976) (0)
Erratum: Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma (Diseases of the Colon and Rectum (May) (640)) (1999) (0)
Know thyself genetically (1999) (0)
Some issues and questions concerning the Human Genome Project (1990) (0)
EGF signaling in bowel carcinoma cells utilizes higher order architectures of EGFR and HER2 (2020) (0)
A handbook for population analysts. Pt B. Reference tables. (1974) (0)
Proceedings of the NATIONAL ACADEMY OF SCIENCES GENETIC UNDER SELECTION (0)
HLA Nomenclature: The Name of the Rose (2000) (0)
Symposium on variation in the human genome, held at the Ciba Foundation, London 13-15 June 1995 - Final discussion (1996) (0)
Charitable support and cancer research; an address to Her Imperial Highness Princess Takamatsu on the occasion of the 20th International Symposium of the Princess Takamatsu Cancer Research Fund. (1990) (0)
Genetics and cancer (1986) (0)
Editorial help (2004) (0)
Letter from Walter F. Bodmer to Paul N. McCloskey, Jr. (1969) (0)
Fear of Enlightenment (1970) (0)
Some issues and questions about the human genome project (1990) (0)
The diversity of mitochondrial sequences in Eurasia (2005) (0)
A SNP approach to HLA typing analysis (2005) (0)
TheHLA system: structure andfunction (1987) (0)
HLA-A, -B, -Cw,-DQA1,-DQB1 and -DRB1 allele frequencies in a Nentsy population from Russia (2004) (0)
Connecting gene expression subtypes of colorectal cancer (CRC) with cell lines and drug resistance. (2013) (0)
Genome research in Europe. (1992) (0)
LA polymorphism in genetic strucure analysis of the aboriginal populations of Northern Russia (2002) (0)
Epidemiology: Report from the PHLS Communicable Disease Surveillance Centre (1988) (0)
Molecular mechanisms of the immune response. Dedicated to Micheal Crumpton. Introduction. (1995) (0)
The enzymes of glycolysis. Introductory remarks to the fourth session: gene organization and evolution. (1981) (0)
Evolutionary perspectives on cancer and aging (2021) (0)
Medical charities and prevention. (1980) (0)
Genetics of the cell surface : a Royal Society discussion organized by W. F. Bodmer, held on 24 March 1977 (1978) (0)
Training for Future Needs (1965) (0)
Proceedings: Analysis of the mitochondrial enzymes citrate synthase (EC 4.1.3.7) and malate dehydrogenase (EC 1.1.1.37) in human-mouse somatic cell hybrids. (1974) (0)
Polyp number and clonality in Min mouse aggregation chimaeras (1999) (0)
Epigenetic control of CD24 expression in colorectal cancer (2016) (0)
A Scientific Approach to the Study of Movement (1958) (0)
Experimental intestinal carcinogenesis (1986) (0)
R. A. Fisher – 50 years on (2012) (0)
Cancer Immunotherapy: Where Next? (2023) (0)
Strategies for Chronic Disease Control: Royal Society, Chairman's Introduction, Sir Walter Bodmer, John Fox, Nubia Munoz, Sarah Darby: Tape 1 (2017) (0)
Social concern and biological advances. (1977) (0)
MiR-215 regulates differentiation in colorectal cancer stem cells (2014) (0)
Immunogenetics: chairman's introduction. The evolution and function of the HLA system. (1989) (0)
RECOMBINANT DNA TECHNOLOGY AND HUMAN DISEASE (1981) (0)
HUGO'S finances (1990) (0)
Molecular and genetic organization: the future. (1979) (0)
Mathematical modelling of cell population dynamics in the colonic crypt with application to colorectal cancer (2008) (0)
The influence of charitable foundations on medical research policy. (1994) (0)
Models for DNA mediated bacterial transformation (1967) (0)
Letter from Walter F. Bodmer to Joshua and Esther Lederberg (1962) (0)
Report from the PHLS Communicable Disease Surveillance Centre. (1986) (0)
R.C.P. Compilation: Charles Fletcher, Richard Doll, Janet Vaughan, Cyril Clarke, Walter Bodmer, Richard Schilling, Archie Cochrane, John Badenoch, Peter Tizard, Raymond Hoffenberg, Douglas Black, Norman Heatley, Gustav Nossal (2017) (0)
Regulation of stemness and differentiation in colorectal cancer (2010) (0)
Hype from journalists and scientists (1992) (0)
Sir Walter Bodmer FRS in interview with Dr Max Blythe: Interview 2 (2017) (0)
Criteria for choosing non-patient control groups in genetically based case-control studies in the United Kingdom. People of the British Isles: the pilot project (2007) (0)
Nomenclature for factors of the HLA system, 2000. (2001) (0)
The Issue of 'Bad Heredity' (1966) (0)
Successful Science Communication: Plate section (2011) (0)
The Triple Helix: the undergraduate student-run face of science communication (2011) (0)
The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland (2017) (0)
A Haldane perspective from a Fisher student (2017) (0)
Has HLA diversity been influenced by seafaring in Northern Europe (2006) (0)
Tissue Aitigens (0)
Letter from Walter F. and Julia Bodmer to Joshua and Esther Lederberg (1963) (0)
Identifying prostate cancer risk loci on chromosome 12 in African Americans using an admixture mapping approach (2009) (0)
A NON-SIGNIFICANT HETEROGENEITY CHI SQUARE2 (2016) (0)
The power of the podcast: the Naked Scientists' story (2011) (0)
Oncogenes, their role in normal and malignant growth : proceedings of a Royal Society Discussion Meeting held on 5 and 6 December 1984 (1985) (0)
Aleksandrov, AD, AN Kolmogorov, and MA Lavrent'ev. Mathemat-ics: Its Content, Methods and Meaning. 3 vols. in one. Mineola: Dover Publications, 1999.(First published in 1963). Pp xv+ 1120. $29.95 (paper). Beller, Mara. Quantum Dialogue: The Making of a Revolution. Chicago and (2000) (0)
GENETICS OF CELL-SURFACE - INTRODUCTION (1978) (0)
Focus : Current issues in medical ethics Our future inheritancel (2005) (0)
Injection moulded pinched flow fractionation device for cell separation (2013) (0)
Abstract 4228: PLAP (placental alkaline phosphatase)-CAR-T cells specifically target colorectal cancer (2020) (0)
Monoclonal antibodies useful in the diagnosis and treatment of colorectal cancer (1994) (0)
Failure to satisfy the Amsterdam criteria for diagnosis of HPNCC should not preclude 'at risk' families from predictive genetic testing (1998) (0)
Nomenclature for factors of the HLA system-1977. (1978) (0)
A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening (2020) (0)
Abstract LB-B11: Development and validation of ColoScape™: A new colorectal cancer mutation detection assay™ (2017) (0)
The origin of colorectal neoplasms: Clues to the origin of human cancer (1997) (0)
Serological Identification of la Antigens: Report of a British Region la Workshop (2008) (0)
Population comparisons using a range of genetic markers (2002) (0)
DEVELOPMENT OF A SYSTEM OF EXPRESSION CLONING FOR MOLECULES COSTIMULATORY FOR T-CELLS (1994) (0)
Centromere * * * HLA * Recombination ' hot ' spot (2005) (0)
A Haldane perspective from a Fisher student (2017) (0)
Abstract 3900: Plasma ctDNA multigene mutation analysis for the diagnosis and treatment monitoring of colorectal cancer patients (2018) (0)
PNAS Plus Significance Statements (2015) (0)
Isolation of a polymorphic DNA sequence (lambda EMBL3.303, D2S14) from chromosome 2. (1987) (0)
Advances in the applications of monoclonal antibodies in clinical oncology. Abstracts. (1984) (0)
A family affair (2004) (0)
The genetic structure of the British populations and their surnames (2016) (0)
52. Development of a human CEA transgenic mouse model (2001) (0)
Spectral Karyotyping reveals a new subset of colorectal cancers characterized by balanced translocations (2001) (0)
What's wrong with the funding of cancer research? (1982) (0)
Nomenclature for factors of the HLA system, 1990 (2004) (0)
Biochemical analyses of human class II histocompatibility (HLA-D region) antigen- associated invariant polypeptides (1984) (0)
HLA-A LOCUS SPECIFICITIES IDENTIFIED BY SEQUENCE SPECIFIC PCR (1993) (0)
EGF signalling in epithelial carcinoma cells utilizes preformed receptor homoclusters, with larger heteroclusters post activation (2018) (0)
Colorectal Cancer and the Rare Variant Hypothesis (2007) (0)
Simple and effective SNP detection without gels (2001) (0)
DEMONSTRATION OF TWO DISTINCT LIGHT CHAINS IN HLA-D REGION ANTIGENS (1981) (0)
Molecular analysis of the HLA-D region genes. (1983) (0)
Tales from the Crypt (2007) (0)
p53 status and the regression of rectal cancer following preoperative chemoradiotherapy (2000) (0)
Clinical features and molecular analysis of a family with multiple colon tumours and reduced plasminogen activator activity (1997) (0)
Mono clonal antibodies to human t lymphocyte sub populations (1981) (0)
Nomenclature for factors of the HLA system 1984. (1985) (0)
Genetic markers and local history: A study in Orkney (2002) (0)
Paul Ichiro Terasaki (1929-2016): Inventor of the microcytotoxicity assay and pioneer tissue typer. (2016) (0)
The HLA system and severe pre-eclampsia (1980) (0)
The genetics of the human face: identification of large effect single gene variants (2017) (0)
Somatic selection of poorly differentiating variant stem cell clones could be a key to human ageing (2020) (0)
The strategy of gene assignment using hybrids: the number of lines needed to exclude chance associations. (1975) (0)
Books Received (1972) (0)
Cyclin D1 rare variants in UK and French multiple adenoma and early onset colorectal cancer patients (2018) (0)
familial adenomatous polyposis . APC mutation associated with late onset of (0)
Nomenclature for factors of the HLA system, 1995. (1995) (0)
Biometrical Genetics. Proceedings of an International Symposium Held at Ottawa, August 1958. (1960) (0)
THE NEED FOR A WELL CHARACTERISED UK CONTROL POPULATION (2008) (0)
Nomenclature for factors of the HLA system, 1990. WHO Committee for Factors of the HLA System. (1991) (0)
Editorial. Launching a new medical journal. (1971) (0)
Editor's Reply (1991) (0)
DETECTION OF MUTATIONS IN GENES OF THE WNT SIGNALLING PATHWAY IN PROSTATE CANCER USING LASER MICRODISSECTION AND WHOLE GENOME AMPLIFICATION (2006) (0)
Reply: In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies (2008) (0)
Isolation of a DNA sequence (lambda EMBL3.123, D4S64) from chromosome 4 showing a BglII polymorphism. (1987) (0)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1994 (1994) (0)
Models of environmental effects on intestinal tumour development (1997) (0)
Targeted killing of colorectal cell lines and murine adenomas using a monoclonal antibody against membrane bound carcinoembryonic antigen (2006) (0)
Abstract 5172: Whole exome mutation landscape of 70 commonly used colorectal cancer cell lines (2014) (0)
EVENTS OCCURRING AT THE SITE OF INTEGRATION OF A DNA MOLECULE IN BACZLLUS SUBTZLZS (2003) (0)
A fluorescence based cell adhesion assay using terasaki plates (1995) (0)
The Handbook of Man (1991) (0)
1200 Drug responses and predictive markers for sensitivity in colorectal cancer cell lines (2009) (0)
901 AN AUTOMATED CIRCULATING TUMOUR CELL BASED ASSAY FOR PROSTATE CANCER THAT MAINTAINS THE INTEGRITY OF THE TUMOR CELLS DETECTED (2009) (0)
Author Correction: The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland (2018) (0)

This paper list is powered by the following services:

Other Resources About Walter Bodmer

en.wikipedia.org

What Schools Are Affiliated With Walter Bodmer?

Walter Bodmer is affiliated with the following schools: